A B S T R A C T The main objective of this study was to determine whether the principal abnormality of thyroid function observed in patients with chronic renal failure, low serum triiodothyronine (T3) concentration, causes hypothyroidism at the tissue level. A partially nephrectomized (Nx) uremic rat model was developed and the following parameters of thyroid function were assessed: serum total thyroxine (TT4), total T3 (TT3), and thyrotropin and liver T3 content, and activity oftwo thyroid hormone-dependent enzymes, mitochondrial a-glycerophosphate dehydrogenase (aGPD) and cytosol malate dehydrogenase (MDH). The results were compared to those of intact control (C), thyroidectomized (Tx), and nephrectomized-thyroidectomized (NxTx) littermates.
The NxTx rats showed the combined effects ofnephrectomy and thyroidectomy; blood urea nitrogen was elevated to 203, and serum levels of TT4, TT3, and thyrotropin were 0.4, < 10, and 2,525, respectively. Total liver T3 and aGPD and MDH were strikingly low; the corresponding values were 3.5, 2.4, and 2.5.
L-triiodothyronine replacement (0.4 ,ug/100 g body wt/d) for 4 wk in the Nx rats resulted in significant increases in liver enzyme activities, aGPD and MDH rose by 70 and 60% over their respective basal values without alteration in the severity of azotemia.
From these data, we conclude that the reduction of liver T3 content in the uremic rats, accompanied by a decrease in aGPD and MDH activity, indicates the presence ofhypothyroidism at the tissue level. Restoration of enzyme activities toward normal levels after T3 administration provided further supporting evidence that the diminution in liver enzyme activity was causally related to tissue T3 deficiency.
INTRODUCTION
Patients with chronic renal failure have low serum levels of total triiodothyronine (TT3)1 due, in part, to a defect in the peripheral conversion of thyroxine (T4) to triiodothyronine (T3) (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) . However, the physiologic significance of the low serum T3 concentration in a variety of conditions (4) (5) (6) , including uremia, has not been clearly defined. Thus, the question ofwhether uremic patients are hypothyroid remains unanswered. Investigators who propose that uremic patients are euthyroid base their conclusion on the observation that serum thyrotropin (TSH) is not elevated and thyroid function tests, independent of hormone measurements such as the basal metabolic rate, the systolic time interval, and the deep tendon reflex relaxation time, are normal (7) . The argument for hypothyroidism is purely theoretical and is based on the concept that T3 is the hormone through which the major metabolic effects of T. are exerted (12, 13) . The absence of TSH elevation should not be regarded as unequivocal evidence of euthyroidism because disturbances in the hypothalamicpituitary axis are known to occur in uremia (14) (15) (16) (17) . The controversy regarding thyroid status in uremia is partly because most studies have concentrated on the measurement of thyroid hormone in serum. There is no information available on the content of T3 in tissues. This is important because the bulk of extrathyroidal T3 is generated in the peripheral tissues, at the sites of action (12, 13) .
We studied thyroid function in a uremic rat model. T3 concentrations in serum as well as in liver were measured. In addition, the activities of two liver enzymes regulated by thyroid hormone (18) (19) (20) (21) , mitochondrial a-glycerophosphate dehydrogenase (aGPD) and cytosol malate dehydrogenase (MDH), were determined. The results showed an early reduction in liver T3 content accompanied by a significant diminution in both enzyme activities. These data, coupled with the correction of the observed enzyme deficiencies after T3 treatment, suggest that hypothyroidism at the tissue level accompanies the uremic state.
METHODS

Experimental design
Four groups of rats, control (C), thyroidectomized (Tx), nephrectomized (Nx), and nephrectomized-thyroidectomized (NxTx), were examined. The Nx rats were studied 4, 5, and 6 wk after nephrectomy. Male Sprague Dawley rats, weighing 120-150 g at the start of each experiment, were obtained from Animal Resource Laboratory, Madison, Wis. Uremic rats were prepared by a two-stage 5/6 nephrectomy. The upper and lower poles of the left kidney were removed by ligation and the raw surfaces were cauterized to prevent bleeding and minimize compensatory hypertrophy. The entire right kidney was removed 5-7 d later. Only 50-60% of the Nx rats were used; 30-40% died within 72 h of the second stage of nephrectomy and another 10% were discarded because blood urea nitrogen (BUN) was insufficiently elevated (<50 mg/dl). Thyroidectomy was performed by a standard surgical technique. Mortality in the Tx group was negligible and hypothyroidism always ensued. In the NxTx rats, thyroidectomy was done 5 wk after nephrectomy. As these rats appeared very ill, studies were performed 3-5 d after thyroidectomy. The mortality in this group was -75%. About 70% survived the second stage of nephrectomy but only 25% survived the subsequent thyroidectomy. Unless otherwise specified, rats were fed regular chow and given access to tap water ad lib. Tx and NxTx rats were given 0.9% calcium chloride as the drinking water. In addition, NxTx rats received 10 mg of calcium gluconate, by intraperitoneal injection, every other day after thyroidectomy.
In another experiment, only C and 6-wk Nx rats were used.
Each group was further divided in half; one-half received no treatment whereas the other received exogenous L-triidothyronine (Sigma Chemical Co., St. Louis, Mo.) supplement at 0.4 yg/100 g of body wt/d by intraperitoneal injections for 4 consecutive wk starting 2 wk after the second stage of nephrectomy. The dose was considered to be optimal for T3 replacement based on the studies by Garcia et al. (22) on the effect of T3 on TSH response to TSH-releasing hormone in Tx rats. Rats were killed by cardiac exsanguination under light ether anesthesia. The liver was perfused in situ with normal saline solution until light tan. The entire liver was removed and weighed. 1 g was frozen on dry ice immediately and kept at -30°C until extraction was done on another day for measurement ofT3 content. Additionally, 1 gram ofliver was processed freshly for quantitation of mitochondrial aGPD activity and another 2 g for determination of MDH activity. The two kidneys of C and Tx rats and the kidney remnants of Nx and NxTx rats were removed and weighed. Serum was saved for measurements of BUN, total thyroxine (TT4), free thyroxine index (FT4IJ), T4 binding capacity, TT3, and thyroid stimulating hormone (TSH). In the rats that received exogenous T3 treatment, additional serum samples were obtained 2 h after the last T3 injection for determination of TT3 levels.
As serum thyroid hormone concentrations (23) and aGPD and MDH activities (24) vary with age, littermates were used for each experiment. Execution of surgical procedures was staggered so that rats in each experimental group were of the same age at the time of study.
Analytical procedures
Determination ofT3 content. Liver T3 was extracted using the method of Nejad et al. (25) . Briefly, 1 g of frozen liver was homogenized in 2 ml of chilled water containing 50 itM propylthiouracil. 10 ,ul of the homogenate was saved for protein determination and the remainder was extracted twice with 6 ml of 95% ethanol. An equal volume of chloroform (12 ml) was added to the pooled ethanol extract placed in a separatory funnel. T3 was extracted from the ethanol-chloroform mixture using 1/3 vol of 2 N NH40H three times. The pooled aqueous phase was concentrated in a flash evaporator and subsequently lyophilized. The residue was reconstituted in 0.5 M phosphate buffer containing 1% bovine serum albumin, pH 7.5, and was stored at -20°C until analyzed for T3 content.
Recovery was monitored in every batch of T3 extraction by addition of sufficient [ln2I]T3 to a second 1 g piece of liver before extraction and corrections for recovery were carried out for each sample. Assessment ofenzyme activity. Mitochondrial aGPD (EC 1.1.1.8) activity was measured in the mitochondrial fraction prepared from 1 g of freshly perfused liver. Homogenization was done in 9 vol of 0.25 M sucrose, 50 mM Tris-HCl, pH 7.5. After centrifugation at 1,000 g, 4°C for 10 min, the supernate was again centrifuged at 12,000 g, 4°C for 10 min, and the resultant pellet containing mitochondria was resuspended in 1 ml of 0.125 M phosphate buffer, pH 7.5. aGPD activity was analyzed in triplicate (three sets of blanks and samples) according to the method of Lee and Lardy (19) . Reactions were carried out for 15 min. The difference in the mean optical density in the assay tubes and in the blanks read at 500 nm (AOD) and the protein concentration, measured in an aliquot of the mitochondrial preparation, was used for the calculation of the enzyme activity expressed as AOD per minute per total liver and per mg of protein.
Cytosol MDH (EC 1.1.1.40) activity was measured in 2 g of fresh liver. Homogenization was done in 3 vol of chilled 0.25 M sucrose. The homogenate was centrifuged at 9,000 g 4°C for 10 min, and the supemate was recentrifuged at 100,000 g, Tissue Hypothyroidism in a Uremic Rat Model 947 4°C for 60 min. This supernate, containing the cytosol fraction, was passed through a 0.22 itMillipore filter (Millipore Corp., Bedford, Mass.) and diluted 5-or 10-fold with a solution containing 10 mM EDTA, 50 mM Tris HCI, 200 mM magnesium acetate, and 2 mM 2-mercaptoethanol, pH 7.4. MDH activity was then measured using the method of Ochoa (26) as modified by Hsu and Lardy (27) , by monitoring the reduction of NADP to NADPH, producing changes in the optical density at 340 nm. Appropriate blanks, without added substrate, and a standard preparation of purified chicken liver enzyme (Sigma Chemical Co., St. Louis, Mo.) were used in each assay. Enzyme activity was expressed as units of MDH per milligram of cytosol protein and per total liver.
Other measurements. Serum TT4 was measured by a competitive binding assay and the results of a resin T4 uptake test were used to calculate FT4I. as described (28) .
Serum and tissue T3 were measured by a radioimmunoassay (29) using a specific antiserum, a gift from Dr. G. Burke (Cook County Hospital, Chicago, Ill.). Determinations in serum were carried out in the presence of 8-anilino-1-naphthalene sulfonic acid and those in tissues were done in the absence of this substance. Corresponding standard curves contained hypothyroid rat serum or buffer only. The sensitivity of the assay was 10 ngldl and the intra-and interassay coefficients of variation were 7 and 15%, respectively. Serum T4 binding capacity was measured by saturation (30) and expressed as percent of control.
Serum TSH was measured by a radioimmunoassay (31) using materials from two kits (Nos. 3 and 4) obtained from National Institute of Arthritis Metabolism and Digestive Diseases. The assay sensitivity was 100 ng/ml. The intra-and interassay coefficients ofvariation were 3.1 and 16.4%, respectively.
The BUN was determined by the standard microcolorimetric technique with diacetyl monoxime and ferric nitrate reagents.
Protein concentration was measured using the method of Lowry (32 
RESULTS
Kidney and thyroid function of all groups of rats are compared in Table I . After nephrectomy, mean BUN in the Nx rats increased fivefold and the mean weight (Figs. 1 and 2 ). Significant positive correlations were found when the Nx rats were examined independently of the C and Tx rats. There was no significant difference when the tm were compared. Control rats having and greater enzyme activities wer upper section whereas the Tx rats wit peritoneal injection for 4 wk. Statistically significant differences between control and nephrectomized rats were indicated by **, P < 0.005 to <0.0005 using one-tailed t test.
Mean serum TT4 (jLg/dl) levels were 2.5+0.2 and 1.5±0.2, respectively, for the treated C and treated Nx rats. Data for untreated groups are in Table I .
DISCUSSION
The main objective of this study was to examine the physiologic significance of the principal abnormality associated with chronic renal failure, low serum T3 concentration (1, (4) (5) (6) (7) (8) (9) , by searching for evidence of hypothyroidism at the tissue level. We attempted to answer the question by quantitation of T3 content in the liver and by measurement ofthe activities oftwo thyroid hormone-dependent hepatic enzymes. A uremic rat model produced by a two-stage 5/6 nephrectomy was developed. After an initial 30% loss ofbody weight, a stable and reproducible form of chronic azotemia was achieved with a five-to sixfold elevation ofBUN during the entire period of observation. More importantly, the uremic rat exhibited changes ofthyroid function typical ofman with chronic renal failure (1-11) andthus constituted a suitable experimental model. There was a slight decrease in serum TT4, FT4I1, and a marked diminution in serum TT3 concentration; serum TSH level was normal or slightly reduced (Table I ). In the NxTx rats, serum TT4 and FT4I1 were decreased to the same extent as in the Tx rats, but serum TT3 was reduced to a greater degree. This observation indicated that the low serum TT3 in NxTx rats is not only due to lack of T4 but also to an impairment in T4 to T3 conversion caused by uremia. An important finding in this study was a reduction in liver T3 content in the Nx rats. The decrease was most marked when expressed as T3 content per total liver, an average of 50% of the control values 6 wk after nephrectomy (Table II) . The reduction in liver T3 was also significant when expressed as nanograms per milligram protein. It is unlikely that the decrease in liver T3 is due to a lack of T4 as serum TT4 was only slightly T FIGURE 4 Effect of T3 treatment on liver T3 and aGPD and MDH activities in C (E) and Nx (9) rats. Values, representing mean±SEM, are depicted for nontreated (-) Fig. 1 , changes in aGPD paralleled those of T3 content. A similar correlation was found between the MDH activity and liver T3 content in the 6-wk Nx rats (Fig. 2) . The linear regressions correlating liver enzyme activities and T3 content were not different in azotemic rats when compared to Tx and C rats with intact renal function.
It is unlikely that starvation was responsible for the reduction in enzyme activities in the uremic rat as enzymes were restored to normal despite failure of these animals to achieve a higher body weight during the 4-wk period of T3 replacement. The possibility that metabolic consequences directly related to uremia, rather than reduced T3 supply, were responsible for the observed enzymatic changes, was considered. In fact, although thyroid hormone replacement in the Tx rats is known to correct the activity of these two liver enzymes (20) , it has been shown that the apparently T3-deficient severely starved and partially hepatectomized rats are resistant to the induction of liver MDH by thyroid hormone (35) . Relative resistance of the starving rat to a single dose ofT3 by augmentation in resting oxygen consumption has also been demonstrated (37) . Nevertheless, chronic administration of physiologic doses of T3 prevented the diminution of GPD and MDH activities seen in the uremic rat. Such an observation underscores the causal relationship between tissue T3 and enzyme induction in this animal model, especially when the increase in enzyme activities was associated with a repletion of T3 content (Fig. 4) . The slightly higher liver T3 content in the C rats given T3 is either due to a more efficient endogenous generation of T3 from the residual nonsuppressible T4 in these rats or, alternatively, to abnormal catabolism of T3 in the Nx rats. It is important to note that although T3 treatment prevented the decline in liver enzyme activity in the uremic rat, it had no effect on the magnitude of weight loss or the degree of uremia associated with nephrectomy.
Although these data clearly indicate that the reduction of liver aGPD and MDH activities in uremia is causally related to tissue T3 deficiency, they are in apparent contradiction with results reported in the starving and partially hepatectomized rats, models bearing similarities with the uremic rat. The resistance to T3 in the starving and partially hepatectomized rats was manifested by the failure to observe an increase in MDH but not aGPD activity after the administration of a single pharmacologic dose of T3 (35) . Unlike uremic and hypothyroid rats (20) , basal enzyme activity in these acute experimental models was not decreased (35) . No resistance to T3 was observed in fasting human subjects with low serum TT3 when the hormone was given chronically and in physiologic doses (38) .
The lack of TSH elevation in the presence of tissue hypothyroidism and low serum levels of TT3 and TT4 in the uremic rats is puzzling. It certainly could not be attributable to low TSH reserve in the pituitary as serum TSH in the NxTx rats reached levels as high as in the nonuremic Tx rats (Table I) . It is possible that intrapituitary T3 content is normal in the uremic rats as monodeiodination of T3 tends to be more efficient in the pituitary (39, 40) . In such an instance, hypothyroidism would only be confined to the peripheral tissue, including the liver. Alternatively, there may be concomitant disturbances in the hypothalamic-pituitary axis with regard to TSH secretion associated with uremia. Impaired TSH response to TSH-releasing hormone is well documented in patients with chronic renal failure (8, 9) . A resetting of the feedback regulation of TSH secretion at a lower level, proposed as the mechanism responsible for the failure to observe serum TSH elevation in response to starvation-induced decrease in T3 generation in man (38) , may also be operational in the uremic rat model. In summary, the partially nephrectomized rat was an excellent experimental model to examine thyroid function in renal failure because uremia was chronic and stable and the changes in thyroid hormone profile in the circulation were surprisingly similar to that found in patients with chronic renal failure. In this model, T3 content was markedly reduced and the aGPD and MDH activities were also significantly decreased. These data were interpreted as evidence consistent with hypothyroidism at the tissue level. Restoration of enzyme activity after T3 treatment lent further support to this hypothesis. The physiologic significance ofthese findings with regard to total body economy and energy metabolism remains to be elucidated.
